PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
1.17M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
-1.16
No peer data available for comparison.
-30.77M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
43.49M
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-100.00%
Worse than VKTX's revenue growth rate of 0.00%.
-37.43M
Worse than VKTX's ebitda of 0.00.
100.00%
Equal to VKTX's ebitda margin of 100.00%.
-38.24M
Worse than VKTX's ebit of 0.00.
100.00%
Equal to VKTX's ebit margin of 100.00%.
811.00K
Worse than VKTX's depreciation of 0.00.
72.90M
Better than VKTX's total cash of 0.00.
100.00%
Equal to VKTX's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to VKTX's receivables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to VKTX's inventories as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to VKTX's payables as percentage of revenue of 100.00%.
-11.00K
Better than VKTX's capital expenditure of 0.00.
100.00%
Worse than VKTX's capex as percentage of revenue of 0.00%.
4.99%
Better than VKTX's weighted average cost of capital (wacc) of 8.95%.
5.02%
Better than VKTX's cost of equity of 8.95%.
4.08%
Better than VKTX's cost of debt of 6.98%.
-0.23
Better than VKTX's beta of 0.99.
30.07M
Better than VKTX's diluted shares outstanding of 94.35M.
1.57M
Worse than VKTX's total debt of 1.26M.
49.31M
Worse than VKTX's total equity of 3.96B.
50.89M
Worse than VKTX's total capital of 3.96B.
3.09%
Worse than VKTX's debt weighting of 0.03%.
96.91%
Worse than VKTX's equity weighting of 99.97%.
-38.24M
Worse than VKTX's ebiat of 0.00.
-45.40M
Worse than VKTX's unlevered free cash flow of -7.51M.
2.00%
Equal to VKTX's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than VKTX's net debt of -54.26M.
71.33M
Better than VKTX's equity value of 47.36M.
2.37
Better than VKTX's equity value per share of 0.50.